144 related articles for article (PubMed ID: 19356058)
1. LC-MS/MS-based approach for obtaining exposure estimates of metabolites in early clinical trials using radioactive metabolites as reference standards.
Zhang D; Raghavan N; Chando T; Gambardella J; Fu Y; Zhang D; Unger SE; Humphreys WG
Drug Metab Lett; 2007 Dec; 1(4):293-8. PubMed ID: 19356058
[TBL] [Abstract][Full Text] [Related]
2. Obtaining exposures of metabolites in preclinical species through plasma pooling and quantitative NMR: addressing metabolites in safety testing (MIST) guidance without using radiolabeled compounds and chemically synthesized metabolite standards.
Vishwanathan K; Babalola K; Wang J; Espina R; Yu L; Adedoyin A; Talaat R; Mutlib A; Scatina J
Chem Res Toxicol; 2009 Feb; 22(2):311-22. PubMed ID: 19067650
[TBL] [Abstract][Full Text] [Related]
3. Potential bias and mitigations when using stable isotope labeled parent drug as internal standard for LC-MS/MS quantitation of metabolites.
Jian W; Edom RW; Xu Y; Gallagher J; Weng N
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(31):3267-76. PubMed ID: 21056016
[TBL] [Abstract][Full Text] [Related]
4. Quantitation of parent drug and its unstable metabolites by in situ coulometric oxidation and liquid chromatography-tandem mass spectrometry.
Tong W; Chowdhury SK; Su AD; Alton KB
Anal Chem; 2010 Dec; 82(24):10251-7. PubMed ID: 21105697
[TBL] [Abstract][Full Text] [Related]
5. A simple liquid chromatography-tandem mass spectrometry method to determine relative plasma exposures of drug metabolites across species for metabolite safety assessments (metabolites in safety testing). II. Application to unstable metabolites.
Gao H; Obach RS
Drug Metab Dispos; 2012 Jul; 40(7):1290-6. PubMed ID: 22456937
[TBL] [Abstract][Full Text] [Related]
6. Bio-generation of stable isotope labeled internal standards for absolute and relative quantitation of drug metabolites in plasma samples by LC-MS/MS.
Li P; Gong Y; Lim HK; Jian W; Edom RW; Salter R; Silva J; Weng N
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 926():92-100. PubMed ID: 23562907
[TBL] [Abstract][Full Text] [Related]
7. Challenges in the indirect quantitation of acyl-glucuronide metabolites of a cardiovascular drug from complex biological mixtures in the absence of reference standards.
Srinivasan K; Nouri P; Kavetskaia O
Biomed Chromatogr; 2010 Jul; 24(7):759-67. PubMed ID: 20014146
[TBL] [Abstract][Full Text] [Related]
8. A simple liquid chromatography-tandem mass spectrometry method to determine relative plasma exposures of drug metabolites across species for metabolite safety assessments.
Gao H; Deng S; Obach RS
Drug Metab Dispos; 2010 Dec; 38(12):2147-56. PubMed ID: 20847138
[TBL] [Abstract][Full Text] [Related]
9. Use of relative 12C/14C isotope ratios to estimate metabolite concentrations in the absence of authentic standards.
Cuyckens F; Pauwels N; Koppen V; Leclercq L
Bioanalysis; 2012 Jan; 4(2):143-56. PubMed ID: 22250797
[TBL] [Abstract][Full Text] [Related]
10. A novel LC-MS approach for the detection of metabolites in DMPK studies.
Plumb RS; Mather J; Little D; Rainville PD; Twohig M; Harland G; Kenny DJ; Nicholson JK; Wilson ID; Kass IJ
Bioanalysis; 2010 Oct; 2(10):1767-78. PubMed ID: 21083328
[TBL] [Abstract][Full Text] [Related]
11. Use of high-resolution mass spectrometry to investigate a metabolite interference during liquid chromatography/tandem mass spectrometric quantification of a small molecule in toxicokinetic study samples.
Furlong M; Bessire A; Song W; Huntington C; Groeber E
Rapid Commun Mass Spectrom; 2010 Jul; 24(13):1902-10. PubMed ID: 20533320
[TBL] [Abstract][Full Text] [Related]
12. Fractional mass filtering as a means to assess circulating metabolites in early human clinical studies.
Tiller PR; Yu S; Bateman KP; Castro-Perez J; McIntosh IS; Kuo Y; Baillie TA
Rapid Commun Mass Spectrom; 2008 Nov; 22(22):3510-6. PubMed ID: 18853407
[TBL] [Abstract][Full Text] [Related]
13. Standard-Free Bioanalytical Approach for Absolute Quantitation of Drug Metabolites Utilizing Biosynthesis of Reciprocal Radio and Stable Isotopologues and Its Application.
Gong Y; Chen J; Shi Y; Lim HK; Weng N; Salter R
Anal Chem; 2017 Aug; 89(16):8399-8404. PubMed ID: 28696683
[TBL] [Abstract][Full Text] [Related]
14. Quantitation of drug metabolites in the absence of pure metabolite standards by high-performance liquid chromatography coupled with a chemiluminescence nitrogen detector and mass spectrometer.
Deng Y; Wu JT; Zhang H; Olah TV
Rapid Commun Mass Spectrom; 2004; 18(15):1681-5. PubMed ID: 15282765
[TBL] [Abstract][Full Text] [Related]
15. Targeted LC-MS Analysis for Plant Secondary Metabolites.
Shimizu T; Watanabe M; Fernie AR; Tohge T
Methods Mol Biol; 2018; 1778():171-181. PubMed ID: 29761438
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and Use of Stable-Isotope-Labeled Internal Standards for Quantification of Phosphorylated Metabolites by LC-MS/MS.
Arrivault S; Guenther M; Fry SC; Fuenfgeld MM; Veyel D; Mettler-Altmann T; Stitt M; Lunn JE
Anal Chem; 2015 Jul; 87(13):6896-904. PubMed ID: 26010726
[TBL] [Abstract][Full Text] [Related]
17. Metabolite characterization in drug discovery utilizing robotic liquid-handling, quadruple time-of-flight mass spectrometry and in-silico prediction.
Nassar AE; Adams PE
Curr Drug Metab; 2003 Aug; 4(4):259-71. PubMed ID: 12871044
[TBL] [Abstract][Full Text] [Related]
18. Androgen glucuronides analysis by liquid chromatography tandem-mass spectrometry: could it raise new perspectives in the diagnostic field of hormone-dependent malignancies?
Kalogera E; Pistos C; Provatopoulou X; Athanaselis S; Spiliopoulou C; Gounaris A
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 940():24-34. PubMed ID: 24140653
[TBL] [Abstract][Full Text] [Related]
19. Sensitive and Comprehensive LC-MS/MS Analyses of Chiral Pharmaceuticals and Their Hepatic Metabolites Using Ovomucoid Column.
Todoroki K; Kudoh Y; Nakamura M; Shimizu Y; Sasaki T; Otsuki H; Wada K; Min JZ; Mizuno H; Yoshinari K; Toyo'oka T
Anal Sci; 2018 Sep; 34(9):1011-1015. PubMed ID: 30033954
[TBL] [Abstract][Full Text] [Related]
20.
Hermann G; Schwaiger M; Volejnik P; Koellensperger G
J Pharm Biomed Anal; 2018 Jun; 155():329-334. PubMed ID: 29704823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
